Upcoming Indiana Life Sciences Collaboration Conference Series Event

life sciencesAs a sponsor of the 2014-2015 Indiana Life Sciences Collaboration Conference Series, Pearl Pathways  would like to announce the upcoming conference entitled Mobile Healthcare: Where Does New IT Intersect with Healthcare? We invite you to join us at the event on Friday, February 20th, where a panel of experienced industry professionals will discuss the potential and ever-growing effects of technology use, specifically the use of “smart phones” and new information technology intersects with healthcare.

What: A Discussion on Mobile Healthcare and Where New IT Intersects with Healthcare

Where: IUPUI, Hine Hall (Formerly IUPUI Conference Center), 875 North Street, Indianapolis

When: February 20th, 2015 8:00am-3:15pm

Click here for the registration link.

The Indiana Life Sciences Conference Series is presented by the Kelley School’s Center for the Business of Life Sciences. These conferences provide an opportunity for various industry professionals to discuss important business strategies and solutions to promote the advancement of the life sciences field. To learn more, click here.

Pearl Pathways sponsors Indiana Life Sciences Conference Series

life sciencesPearl Pathways is proud to sponsor of the 2014-2015 Indiana Life Sciences Collaboration Conference Series, presented by the Kelley School’s Center for the Business of Life Sciences. These conferences provide an opportunity for various industry professionals to discuss important business strategies and solutions to promote the advancement of the life sciences field.

Please join us for this year’s first conference on September 12th entitled An Update on the FDA and Global Regulatory Bodies, where a panel of experienced industry professionals will discuss the potential affects of new approval procedures and quality compliance requirements.

What: An Update on the FDA and Global Regulatory Bodies

Where: IU Robert H. McKinney School of Law, 530 W. New York Street, Indianapolis

When: September 12, 2014 8:00am-3:15pm

Click here for the registration link.


To learn more about the Indiana Life Sciences Conference Series, click here.

Join us on February 21st at the Kelley School Life Sciences Event

With China’s economy continuing to develop many people in their population will begin to receive advanced healthcare for the first time. Now it’s time to look to see how China can learn from the healthcare insurance systems from around the world and what opportunities will foreign firms have there.

Join the Indina Life Sciences Collaboration Center to discuss:

The current opportunities in China.

Developing and expanding US and Chinese Business Relationships.

Cultural and regulatory lessons learned from entering the Chinese market.

Pearl Pathways is a proud sponsor of the Kelley School Life Sciences series. If interested click here to register.


Join us at this September 6th event: Indiana as a Life Sciences Hub in 2023 – What will it take?

Indiana University’s Kelley School Center for the Business of Life Sciences is holding their next Life Science Series Collaboration series event on September 6, 2013. Pearl’s COO, Gretchen Bowker will be moderating the morning panel discussion.

Pearl is a proud sponsor of the 2013-2014 Series.

Title: Indiana as a Life Sciences Hub in 2023 – What Will it Take?

Session overview:

With Indiana’s impressive life sciences industry stats one might proudly claim that we are one of the leading life sciences clusters: industry’s $50 bn economic impact to the state, employment of 55,500 workers, 3rd rank in worldwide exports, and nearly one third of the $38 bn orthopedic industry headquartered in Warsaw, IN are a few among many achievements.

However, when compared to the hubs like Boston, New York/New Jersey, and the Bay Area, there is a realization there is still lots of work to do in venture capital and NIH funding, government policies, infrastructure, R&D spending and the development of a highly skilled science and engineering workforce.

Join industry executives, economic developers and political leaders at the conference:

Date: September 6, 2013


IU Robert H. McKinney School of Law

530 W. New York Street, Indianapolis, 46202

Agenda: Gretchen Bowker, COO of Pearl Pathways will be moderating the AM panel discussion.  To see the full agenda, click here.

Look for our staff there!

Click here to register.

Visit Pearl Pathways and the Site Solutions Summit this October

Pearl Pathways will be joining more than 500 clinical executives making the commitment to research site success at the 2013 Site Solutions Summit.

Hosted by the Society for Clinical Research Sites, the Summit provides 3 days of networking and takeaways designed to improve site performance across the clinical enterprise.  Sites come to improve their business and relationships, while sponsor and CRO attendees are looking to improve organizational process and outcomes.

The result is a great meeting, and Pearl Pathways wants to share a special discount code for you to save $200.00 off registration from now until Friday, July 26th.


Where:  Omni Amelia Island Plantation Resort in Amelia Island, FL

When:  October 11-13, 2013

Who:     More than 500 clinical research executives

15-20% Pharma/CRO-Senior Clinical Operations

75-80% Sites-Investigator or C-Level

Why:     10+ hours of incredible industry networking opportunities

36 interactive topics that affect your business, visit the agenda

60 sponsors and CROS, nearly 500 site executives and investigators, and 40 great exhibitors

How:     Sites can save $200 and register through 7/26/13. Please use code – “pearlpath” at the check-out process and register by visiting www.sitesolutionssummit.com .


Sponsors and CROs can send their first attendee for free by contacting denise.davis@myscrs.org and mentioning “pearlpath”.

Q2 IPOs boom with the help of life sciences

Kyle Alspach shares on bizjournals.com that there was biotech boom of venture capital (VC) backed IPOs during the second quarter of 2013. Out of the 21 IPOs funded by VCs, thirteen were categorized as life science related and eleven of those thirteen were biotech. Two of the larger companies included were Cambridge based Bluebird Bio focused on gene therapies, and Epizyme, an oncology company. The 21 VC backed IPOs more than doubled the Q1 eight IPOs encouraging executives in these fields. Mark Heesen, president of the National Venture Capital Association (NVCA), commented “We have been predicting an IPO pickup in the second half of 2013 and it appears as if this momentum has begun, driven by the strong biotechnology offerings.” Now the industry must fight against its past second half of the year slumps, due to negative externalities. For the full article, click here.

IHIF June lunch series discusses Health IT solutions

The IHIF June lunch series will discuss the implementation of Health IT solutions to help coordinate patient information, address challenges in healthcare delivery, and reduce costs of clinical research.  Speakers such as Matthew Kirby, Director of Business Attraction and Development for the Indianapolis Chamber of Commerce, and Kristin Eilenberg, co-founder of INFUSE Accelerator, will share their thoughts about these topics.

Topic: “Health IT – Events, Incubators, and Growing our Cluster”

When: Tuesday, June 18,2013

Registration: 11:30 – 12:00 PM

Presentation: 12:00 – 1:00 PM

Location: Barnes and Thornburg LLP, 11 S. Meridian St., Indianapolis, IN

For more information click here and to register click here.

BioCrossroads’ Frameworx session to be held June 27th

The next Frameworx session will be held later his month with the topic of Indiana Biosciences Research Institute: Laying the framework for discovery, development and delivery of biosciences innovation in Indiana.

Speakers will include Dan Peterson, Cook Medical Group; Darren Carroll, Eli Lilly & Company; David Johnson, BioCrossroads as well others local leaders ready for the next steps.

When: Thursday, June 27, 2013

Time: 8:00 – 10:00 am

Location: D’Amore, 48th floor of Chase tower

111 Monument Circle, Indianapolis, IN 46204

Price: There is no fee

There will be a complimentary breakfast selections.

For more information click here, and to register click here.


Indiana Chapter of AMWA will host conference in June

The Indiana Chapter of the American Medical Writers Association (AMWA) will be holding a conference this June covering topics such as careers in medical communication, enhanced medical writing, DITA, and more. An assortment of speakers throughout the medical writing field will be sharing insight to participants to join for the weekend.

When: Friday and Saturday, June 7-8, 2013

Time: Friday: 8:00 am – 4:45 pm

Saturday: 8:00 am – 4:30 pm

Location: Indiana Farm Bureau Insurance Building (Assembly Room A)

225 S. East Street Indianapolis, IN 46206

Price: No fee but registration is required

To register click here

Lunch: $7.00 box lunches can be provided; you can also bring a lunch or eat at a restaurant nearby

Dinner: Indicate on the registration form if you would like to attend dinner at the Milano Inn on Friday from 5:30 – 7:30 pm. This meal is not free.

Parking is free:

On Friday, park in front of the conference building.

On Saturday, park in the garage behind the building. From East Street or College Avenue, turn on to Georgia Street, which runs along the north side of the building. From Georgia Street, enter the garage by using the intercom to tell security you are coming to the AMWA meeting. Do not park in the visitor lot in front of the building or on top of the parking garage behind the building.

For more information or questions contact David Caldwell, davidccaldwell@att.net.


Crowdfunding increasing in life science industry?

McBride shared in FierceBiotechIT.com, that Mir Imran has launched a crowdfunding website called VentureHealth to assist life science firms in obtaining capital.  Imran has partnered with associates from InCube Ventures, a venture capital (VC) firm in Silicon Valley that specializes in life science deals. The motivation behind creating VentureHealth stems from the 12% drop in life science deals done since 2011 through VCs. Many VCs are leaving the life science industry because of the high regulatory and technical risks, leaving many innovative deals on the table. Imran shares, “Venture capital for early stage life science companies has dried up in the last few years, and promising companies are always looking for investors.” This is where he hopes VentureHealth will step in. The site is targeting high wealth angel investors including physicians. What will be the future of crowdfunding as a source of capital for early stage ventures? Read the full article here.